David B. Rye

19.6k total citations · 2 hit papers
148 papers, 11.7k citations indexed

About

David B. Rye is a scholar working on Cognitive Neuroscience, Neurology and Epidemiology. According to data from OpenAlex, David B. Rye has authored 148 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Cognitive Neuroscience, 56 papers in Neurology and 53 papers in Epidemiology. Recurrent topics in David B. Rye's work include Sleep and Wakefulness Research (78 papers), Restless Legs Syndrome Research (53 papers) and Parkinson's Disease Mechanisms and Treatments (48 papers). David B. Rye is often cited by papers focused on Sleep and Wakefulness Research (78 papers), Restless Legs Syndrome Research (53 papers) and Parkinson's Disease Mechanisms and Treatments (48 papers). David B. Rye collaborates with scholars based in United States, Germany and Italy. David B. Rye's co-authors include Bruce H. Wainer, Allan I. Levey, Clifford B. Saper, Donald L. Bliwise, Henry J. Lee, Elliott J. Mufson, Lynn Marie Trotti, Arthur S. Walters, Ann E. Hallanger and M.‐Marsel Mesulam and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Neurology.

In The Last Decade

David B. Rye

148 papers receiving 11.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology

1999 704 citations David B. Rye et al. profile →
Cortical projections arising from the basal forebrain: A study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase

1984 634 citations David B. Rye et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David B. Rye United States	57	5.6k	5.1k	3.8k	2.8k	2.4k	148	11.7k
Isabelle Arnulf France	68	8.2k 1.5×	2.3k 0.4×	6.8k 1.8×	3.4k 1.2×	566 0.2×	368	15.5k
Qiwu Xu United States	27	2.7k 0.5×	5.8k 1.1×	1.7k 0.5×	482 0.2×	2.1k 0.9×	29	10.7k
Pasquale Montagna Italy	54	3.1k 0.5×	1.1k 0.2×	2.8k 0.7×	1.7k 0.6×	2.8k 1.2×	192	8.7k
Michael Chen United States	15	1.7k 0.3×	2.5k 0.5×	1.5k 0.4×	757 0.3×	734 0.3×	24	6.4k
Henk W. Berendse Netherlands	58	6.0k 1.1×	4.5k 0.9×	5.9k 1.6×	431 0.2×	1.3k 0.6×	203	13.6k
Álex Iranzo Spain	57	4.8k 0.8×	1.2k 0.2×	7.0k 1.9×	3.8k 1.4×	537 0.2×	183	10.1k
Timothy Schallert United States	70	2.3k 0.4×	6.1k 1.2×	5.5k 1.5×	2.0k 0.7×	2.9k 1.2×	218	16.7k
Marie Vidailhet France	68	3.2k 0.6×	6.0k 1.2×	13.3k 3.5×	1.1k 0.4×	1.4k 0.6×	342	17.8k
Seiji Nishino United States	57	11.4k 2.0×	2.3k 0.4×	693 0.2×	979 0.4×	1.3k 0.6×	214	14.9k
William G. Ondo United States	62	4.2k 0.8×	3.2k 0.6×	11.0k 2.9×	5.2k 1.9×	439 0.2×	251	13.6k

Countries citing papers authored by David B. Rye

Since Specialization

Citations

This map shows the geographic impact of David B. Rye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Rye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Rye more than expected).

Fields of papers citing papers by David B. Rye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Rye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Rye. The network helps show where David B. Rye may publish in the future.

Co-authorship network of co-authors of David B. Rye

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Rye. A scholar is included among the top collaborators of David B. Rye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Rye. David B. Rye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cook, Jesse D., et al.. (2024). Validation and performance of the sleep inertia questionnaire in central disorders of hypersomnolence. Sleep Medicine. 121. 352–358. 4 indexed citations

Nash, Abigail I., et al.. (2023). Commonly Used Therapeutics Associated with Changes in Arousal Inhibit GABAAR Activation. Biomolecules. 13(2). 365–365. 6 indexed citations

Saini, Prabhjyot, et al.. (2023). Feigning daytime sleepiness: potential effects on the psychomotor vigilance test. SLEEP. 46(10). 1 indexed citations

Trotti, Lynn Marie, et al.. (2022). The Psychomotor Vigilance Test as a measure of alertness and sleep inertia in people with central disorders of hypersomnolence. Journal of Clinical Sleep Medicine. 18(5). 1395–1403. 20 indexed citations

Almuwaqqat, Zakaria, Jeong Hwan Kim, Shabatun Islam, et al.. (2021). Usefulness of Restless Legs Symptoms to Predict Adverse Cardiovascular Outcomes in Men With Coronary Artery Disease. The American Journal of Cardiology. 162. 41–48. 3 indexed citations

Trotti, Lynn Marie, Donald L. Bliwise, Glenda L. Keating, David B. Rye, & William T. Hu. (2021). Cerebrospinal Fluid Hypocretin and Nightmares in Dementia Syndromes. Dementia and Geriatric Cognitive Disorders Extra. 11(1). 19–25. 8 indexed citations

Connor, James R., Kari A. Duck, Stephanie M. Patton, et al.. (2020). Evidence for communication of peripheral iron status to cerebrospinal fluid: clinical implications for therapeutic strategy. Fluids and Barriers of the CNS. 17(1). 28–28. 13 indexed citations

Chada, Aditya, et al.. (2019). A Sleepy Patient With Frequent Falls. Journal of Clinical Sleep Medicine. 15(11). 1691–1693. 1 indexed citations

Safavynia, Seyed A., Glenda L. Keating, Jonathan A. Fidler, et al.. (2016). Effects of γ-Aminobutyric Acid Type A Receptor Modulation by Flumazenil on Emergence from General Anesthesia. Anesthesiology. 125(1). 147–158. 36 indexed citations

10.

Trotti, Lynn Marie, et al.. (2016). Flumazenil for the Treatment of Refractory Hypersomnolence: Clinical Experience with 153 Patients. Journal of Clinical Sleep Medicine. 12(10). 1389–1394. 45 indexed citations

11.

Weinberger, Jeremy, Charles L. Raison, David B. Rye, et al.. (2014). Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation. Brain Behavior and Immunity. 47. 193–200. 69 indexed citations

12.

Rye, David B., Donald L. Bliwise, Kathy P. Parker, et al.. (2012). Modulation of Vigilance in the Primary Hypersomnias by Endogenous Enhancement of GABA _A Receptors. Science Translational Medicine. 4(161). 161ra151–161ra151. 120 indexed citations

13.

Freeman, A., Sara Radmard, Hyder A. Jinnah, et al.. (2012). Sleep Fragmentation and Motor Restlessness in a Drosophila Model of Restless Legs Syndrome. Current Biology. 22(12). 1142–1148. 78 indexed citations

14.

Georgoulas, George, et al.. (2011). Phasic Electromyographic Metric detection based on wavelet analysis. PubMed. 497–502. 3 indexed citations

15.

García‐Borreguero, Diego, Richard P. Allen, Heike Beneš, et al.. (2007). Augmentation as a treatment complication of restless legs syndrome: Concept and management. Movement Disorders. 22(S18). S476–S484. 67 indexed citations

16.

Decker, Michael J., et al.. (2005). Reduced Extracellular Dopamine and Increased Responsiveness to Novelty: Neurochemical and Behavioral Sequelae of Intermittent Hypoxia. SLEEP. 28(2). 169–176. 56 indexed citations

17.

Parker, Kathy P. & David B. Rye. (2002). Restless legs syndrome and periodic limb movement disorder. Nursing Clinics of North America. 37(4). 655–673. 64 indexed citations

18.

Miller, Gary W., Jeffrey D. Erickson, Shannon Penland, et al.. (1999). Immunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease. Experimental Neurology. 156(1). 138–148. 164 indexed citations

19.

Vitek, Jerrold L., Roy A.E. Bakay, Takao Hashimoto, et al.. (1998). Microelectrode-guided pallidotomy: technical approach and its application in medically intractable Parkinson's disease. Journal of neurosurgery. 88(6). 1027–1043. 218 indexed citations

20.

Staley, Julie K., et al.. (1996). Vesicular monoamine transporter immunoreactivity is reduced in Parkinsons diseased striatum. The Society for Neuroscience Abstracts. 22. 225. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact